Market Access with DGCF: Your Guide to Spain’s Healthcare Authority

The Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (DGCF) is a department within Spain’s Ministry of Health responsible for overseeing, developing, and implementing the country’s pharmaceutical policy. Its primary functions include the public financing and pricing of medicines and healthcare products dispensed through official prescriptions, as well as the management of information regarding the consumption and procurement of these products within the National Health System (Sistema Nacional de Salud – SNS). (sanidad.gob.es)

Core Functions of DGCF

DGCF’s key responsibilities include:

• Evaluation of the SNS Common Services Portfolio: Designing and assessing the SNS common portfolio to ensure equitable and high-quality healthcare nationwide. (sanidad.gob.es)
• Management of Cohesion and Guarantee Funds: Overseeing the Fondo de Cohesión Sanitaria and Fondo de Garantía Asistencial to ensure appropriate financial compensation between autonomous communities for healthcare services provided. (sanidad.gob.es)
• Pharmaceutical Policy Implementation: Leading the execution of pharmaceutical policies, including the pricing and public financing of medicines and medical products, as well as defining specific prescription and dispensing conditions within the SNS. (sanidad.gob.es)

Leadership and Key Contacts

Since August 2022, DGCF has been led by Dr. César Hernández García, who previously served as Head of the Department of Medicines for Human Use at the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). (plantadoce.com)

DGCF Contact Details:

• Address: Ministerio de Sanidad, Paseo del Prado 18-20, 28071 Madrid, Spain
• Phone: +34 91 596 10 00
• Email: cartera-farmacia@sanidad.gob.es

(administracion.gob.s)

Challenges and Opportunities in Working with DGCF

Collaborating with DGCF involves:

• Understanding the Evaluation Processes: Familiarity with DGCF’s criteria and evaluation procedures is crucial for the inclusion of new services and products in the SNS portfolio.
• Timely and Accurate Submissions: Ensuring that all necessary documentation is complete and submitted on time to facilitate the assessment and approval processes.
• Demonstrating Value and Effectiveness: Providing solid evidence that new treatments or services offer value and effectiveness within the SNS framework.

An effective collaboration with DGCF can lead to streamlined market entry and favorable funding and reimbursement outcomes in Spain.

Opportunities with Justin Stindt Consultants

Justin Stindt’s expertise in DGCF ensures:

• Expert Consultant DGCF Submissions: Crafting high-quality submissions for the assessment of healthcare services and pharmaceutical products.
• Market Access DGCF Strategies: Developing strategies aligned with DGCF’s and CIPM’s evaluation framework to optimize market access.
• Specialized DGCF Processes: Providing insights into DGCF’s procedures to enhance compliance and accelerate approvals.

Justin Stindt Consultants specializes in assisting clients to effectively engage with the DGCF and successfully access the Spanish market.